<VariationArchive RecordType="classified" VariationID="928837" VariationName="NM_000157.4(GBA1):c.914del (p.Pro305fs)" VariationType="Deletion" Accession="VCV000928837" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-12-02" DateCreated="2020-06-22" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="916793" VariationID="928837">
      <GeneList>
        <Gene Symbol="GBA1" FullName="glucosylceramidase beta 1" GeneID="2629" HGNC_ID="HGNC:4177" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="155234452" stop="155244627" display_start="155234452" display_stop="155244627" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_003315906.1" start="39475" stop="49650" display_start="39475" display_stop="49650" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="155204238" stop="155214652" display_start="155204238" display_stop="155214652" Strand="-" />
          </Location>
          <OMIM>606463</OMIM>
        </Gene>
        <Gene Symbol="LOC106627981" FullName="GBA recombination region" GeneID="106627981" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="155233639" stop="155240092" display_start="155233639" display_stop="155240092" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_003315906.1" start="38662" stop="45115" display_start="38662" display_stop="45115" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000157.4(GBA1):c.914del (p.Pro305fs)</Name>
      <CanonicalSPDI>NC_000001.11:155237425:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="155237426" stop="155237426" display_start="155237426" display_stop="155237426" variantLength="1" positionVCF="155237425" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="155207217" stop="155207217" display_start="155207217" display_stop="155207217" variantLength="1" positionVCF="155207216" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P218fs</ProteinChange>
      <ProteinChange>P256fs</ProteinChange>
      <ProteinChange>P305fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.155207218del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.155207218del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.155237427del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.155237427del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009783.1" sequenceAccession="NG_009783" sequenceVersion="1" change="g.12272del">
            <Expression>NG_009783.1:g.12272del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042867.1" sequenceAccession="NG_042867" sequenceVersion="1" change="g.3889del">
            <Expression>NG_042867.1:g.3889del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000157.4" sequenceAccession="NM_000157" sequenceVersion="4" change="c.914del" MANESelect="true">
            <Expression>NM_000157.4:c.914del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000148.2" sequenceAccession="NP_000148" sequenceVersion="2" change="p.Pro305fs">
            <Expression>NP_000148.2:p.Pro305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005741.3" sequenceAccession="NM_001005741" sequenceVersion="3" change="c.914del">
            <Expression>NM_001005741.3:c.914del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005741.1" sequenceAccession="NP_001005741" sequenceVersion="1" change="p.Pro305fs">
            <Expression>NP_001005741.1:p.Pro305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005742.3" sequenceAccession="NM_001005742" sequenceVersion="3" change="c.914del">
            <Expression>NM_001005742.3:c.914del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005742.1" sequenceAccession="NP_001005742" sequenceVersion="1" change="p.Pro305fs">
            <Expression>NP_001005742.1:p.Pro305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171811.2" sequenceAccession="NM_001171811" sequenceVersion="2" change="c.653del">
            <Expression>NM_001171811.2:c.653del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165282.1" sequenceAccession="NP_001165282" sequenceVersion="1" change="p.Pro218fs">
            <Expression>NP_001165282.1:p.Pro218fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171812.2" sequenceAccession="NM_001171812" sequenceVersion="2" change="c.767del">
            <Expression>NM_001171812.2:c.767del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165283.1" sequenceAccession="NP_001165283" sequenceVersion="1" change="p.Pro256fs">
            <Expression>NP_001165283.1:p.Pro256fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1366567865" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000157.4(GBA1):c.914del (p.Pro305fs) AND Gaucher disease" Accession="RCV001193339" Version="1">
        <ClassifiedConditionList TraitSetID="6268">
          <ClassifiedCondition DB="MedGen" ID="C0017205">Gaucher disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000157.4(GBA1):c.914del (p.Pro305fs) AND multiple conditions" Accession="RCV002504219" Version="1">
        <ClassifiedConditionList TraitSetID="12838">
          <ClassifiedCondition DB="MedGen" ID="C1842704">Gaucher disease perinatal lethal</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1961835">Gaucher disease type I</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268250">Gaucher disease type II</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268251">Gaucher disease type III</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1856476">Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0752347">Lewy body dementia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3160718">Parkinson disease, late-onset</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-06-22" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27571329</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7655857</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12838" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3762" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Parkinson disease, late-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARKINSON DISEASE, LATE-ONSET, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="Allelic variant" ID="601517.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606463.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606463.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="157140.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600075.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603680.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606463.0048" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607047.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson's disease</ElementValue>
                <XRef ID="Parkinson+Disease/5603" DB="Genetic Alliance" />
                <XRef ID="49049000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Susceptibility to Parkinson's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary late onset Parkinson disease</ElementValue>
                <XRef ID="MONDO:0018466" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PARK</ElementValue>
                <XRef Type="MIM" ID="168600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PD</ElementValue>
                <XRef Type="MIM" ID="168600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17684" />
                <XRef ID="17684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="411602" DB="Orphanet" />
              <XRef ID="C3160718" DB="MedGen" />
              <XRef ID="MONDO:0008199" DB="MONDO" />
              <XRef Type="MIM" ID="168600" DB="OMIM" />
            </Trait>
            <Trait ID="1243" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Diffuse Lewy body disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal dominant diffuse Lewy body disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lewy Body Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lewy body dementia</ElementValue>
                <XRef ID="Lewy+body+dementia/4215" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007488" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DLB</ElementValue>
                <XRef Type="MIM" ID="127750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3243" />
                <XRef ID="3243" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0752347" DB="MedGen" />
              <XRef ID="MONDO:0007488" DB="MONDO" />
              <XRef Type="MIM" ID="127750" DB="OMIM" />
            </Trait>
            <Trait ID="1362" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gaucher disease type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, noncerebral juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GD 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucocerebrosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acid beta-glucosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher's disease, type 1</ElementValue>
                <XRef ID="Gaucher+Disease+Type+1/3002" DB="Genetic Alliance" />
                <XRef ID="62201009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gaucher disease type I</ElementValue>
                <XRef ID="MONDO:0009265" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBA DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="230800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GD I</ElementValue>
                <XRef Type="MIM" ID="230800" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GD1</ElementValue>
                <XRef Type="MIM" ID="230800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2441" />
                <XRef ID="2441" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased ß-glucocerebrosidase, Gaucher disease, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Gaucher Disease; Decreased beta-glucocerebrosidase activity, 2022</CitationText>
              </Citation>
              <XRef ID="355" DB="Orphanet" />
              <XRef ID="77259" DB="Orphanet" />
              <XRef ID="C1961835" DB="MedGen" />
              <XRef ID="MONDO:0009265" DB="MONDO" />
              <XRef Type="MIM" ID="230800" DB="OMIM" />
            </Trait>
            <Trait ID="1363" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, infantile cerebral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, acute neuronopathic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute neuronopathic Gaucher's disease</ElementValue>
                <XRef ID="Gaucher+Disease+Type+2/3003" DB="Genetic Alliance" />
                <XRef ID="12246008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gaucher disease type II</ElementValue>
                <XRef ID="MONDO:0009266" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GD II</ElementValue>
                <XRef Type="MIM" ID="230900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GD2</ElementValue>
                <XRef Type="MIM" ID="230900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2442" />
                <XRef ID="2442" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased ß-glucocerebrosidase, Gaucher disease, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Gaucher Disease; Decreased beta-glucocerebrosidase activity, 2022</CitationText>
              </Citation>
              <XRef ID="77260" DB="Orphanet" />
              <XRef ID="C0268250" DB="MedGen" />
              <XRef ID="MONDO:0009266" DB="MONDO" />
              <XRef Type="MIM" ID="230900" DB="OMIM" />
            </Trait>
            <Trait ID="1364" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GD 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, juvenile and adult, cerebral</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, chronic neuronopathic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, subacute neuronopathic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher Disease, Type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Subacute neuronopathic Gaucher's disease</ElementValue>
                <XRef ID="Gaucher+Disease+Type+3/3004" DB="Genetic Alliance" />
                <XRef ID="5963005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gaucher disease type III</ElementValue>
                <XRef ID="MONDO:0009267" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GD III</ElementValue>
                <XRef Type="MIM" ID="231000" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2443" />
                <XRef ID="2443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased ß-glucocerebrosidase, Gaucher disease, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Gaucher Disease; Decreased beta-glucocerebrosidase activity, 2022</CitationText>
              </Citation>
              <XRef ID="355" DB="Orphanet" />
              <XRef ID="77261" DB="Orphanet" />
              <XRef ID="C0268251" DB="MedGen" />
              <XRef ID="MONDO:0009267" DB="MONDO" />
              <XRef Type="MIM" ID="231000" DB="OMIM" />
            </Trait>
            <Trait ID="1913" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gaucher disease perinatal lethal</ElementValue>
                <XRef ID="MONDO:0011945" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease collodion type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease, perinatal-lethal form</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10675" />
                <XRef ID="10675" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <XRef ID="85212" DB="Orphanet" />
              <XRef ID="C1842704" DB="MedGen" />
              <XRef ID="MONDO:0011945" DB="MONDO" />
              <XRef Type="MIM" ID="608013" DB="OMIM" />
            </Trait>
            <Trait ID="2161" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome</ElementValue>
                <XRef ID="MONDO:0009268" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher disease type 3C</ElementValue>
                <XRef ID="GAUCHER+DISEASE%2C+TYPE+IIIC/8453" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GAUCHER DISEASE, TYPE IIIC</ElementValue>
                <XRef Type="MIM" ID="231005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606463.0006" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12504" />
                <XRef ID="12504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <XRef ID="2072" DB="Orphanet" />
              <XRef ID="C1856476" DB="MedGen" />
              <XRef ID="MONDO:0009268" DB="MONDO" />
              <XRef Type="MIM" ID="231005" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6268" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14198" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gaucher disease</ElementValue>
                <XRef ID="Gaucher+Disease/3000" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018150" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute cerebral Gaucher disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebroside lipidosis syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gaucher splenomegaly</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sphingolipidosis 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucocerebrosidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucosylceramidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucosyl cerebroside lipidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kerasin lipoidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kerasin thesaurismosis</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) and two other subtypes (perinatal-lethal and cardiovascular) is useful in determining prognosis and management. GD type 1 is characterized by the presence of clinical or radiographic evidence of bone disease (osteopenia, focal lytic or sclerotic lesions, and osteonecrosis), hepatosplenomegaly, anemia and thrombocytopenia, lung disease, and the absence of primary central nervous system disease. GD types 2 and 3 are characterized by the presence of primary neurologic disease; in the past, they were distinguished by age of onset and rate of disease progression, but these distinctions are not absolute. Disease with onset before age two years, limited psychomotor development, and a rapidly progressive course with death by age two to four years is classified as GD type 2. Individuals with GD type 3 may have onset before age two years, but often have a more slowly progressive course, with survival into the third or fourth decade. The perinatal-lethal form is associated with ichthyosiform or collodion skin abnormalities or with nonimmune hydrops fetalis. The cardiovascular form is characterized by calcification of the aortic and mitral valves, mild splenomegaly, corneal opacities, and supranuclear ophthalmoplegia. Cardiopulmonary complications have been described with all the clinical subtypes, although varying in frequency and severity.</Attribute>
                <XRef ID="NBK1269" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8233" />
                <XRef ID="8233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301446</ID>
                <ID Source="BookShelf">NBK1269</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased ß-glucocerebrosidase, Gaucher disease, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Gaucher-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Gaucher Disease; Decreased beta-glucocerebrosidase activity, 2022</CitationText>
              </Citation>
              <XRef ID="355" DB="Orphanet" />
              <XRef ID="C0017205" DB="MedGen" />
              <XRef ID="MONDO:0018150" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2670432" SubmissionDate="2020-03-06" DateLastUpdated="2020-06-22" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_001005741.2:c.914del|MedGen:C0017205" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001362093" DateUpdated="2020-06-22" DateCreated="2020-06-22" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7655857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27571329</ID>
          </Citation>
          <Comment>Variant summary: GBA c.914delC (p.Pro305LeufsX31) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.1029delT, p.Tyr343fsX1; c.1192C&gt;T, p.Arg398X; c.1357C&gt;T, p.Gln453X). The variant allele was found at a frequency of 4.1e-06 in 245970 control chromosomes (gnomAD). c.914delC has been reported in the literature in an individual affected with Gaucher Disease (Beutler_1995). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001005741.2:c.914del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Gaucher disease</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0017205" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5468586" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001005741.3:c.914del|OMIM:127750;168600;230800;230900;231000;231005;608013" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002816623" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001005741.3:c.914del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="127750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="168600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="230800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="230900" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="231000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="231005" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608013" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="230800" MappingRef="OMIM">
        <MedGen CUI="C1961835" Name="Gaucher disease type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="230900" MappingRef="OMIM">
        <MedGen CUI="C0268250" Name="Gaucher disease type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2670432" TraitType="Disease" MappingType="Name" MappingValue="Gaucher disease" MappingRef="Preferred">
        <MedGen CUI="C0017205" Name="Gaucher disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="608013" MappingRef="OMIM">
        <MedGen CUI="C1842704" Name="Gaucher disease perinatal lethal" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="127750" MappingRef="OMIM">
        <MedGen CUI="C0752347" Name="Lewy body dementia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="231000" MappingRef="OMIM">
        <MedGen CUI="C0268251" Name="Gaucher disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="168600" MappingRef="OMIM">
        <MedGen CUI="C3160718" Name="Parkinson disease, late-onset" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468586" TraitType="Disease" MappingType="XRef" MappingValue="231005" MappingRef="OMIM">
        <MedGen CUI="C1856476" Name="Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

